Drug Information

Drug General Information
Drug ID
D0Y8PM
Former ID
DCL000871
Drug Name
LJP-1082
Drug Type
Small molecular drug
Indication Hughes syndrome [ICD9: 289.81; ICD10:D68.8] Discontinued in Phase 1 [547236]
Company
La Jolla Pharmaceutical
Structure
Download
2D MOL

3D MOL
Formula
C23H30N6O
Canonical SMILES
CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)N=[N+]=[N-<br />])OC
InChI
1S/C23H30N6O/c1-5-29(6-2)13-7-8-16(3)25-23-19-11-9-17(27-28-24)14-22(19)26-21-12-10-18(30-4)15-20(21)23/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26)
InChIKey
OJZRYFDOXJOKNZ-UHFFFAOYSA-N
PubChem Compound ID
3037609
PubChem Substance ID
36105454, 57353638, 76362956, 111643930, 134339328, 134340405, 135169060
Target and Pathway
Target(s) Beta-2-glycoprotein 1 Target Info Inhibitor [536055]
References
Ref 547236Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014345)
Ref 536055Emergence of targeted immune therapies for systemic lupus. Expert Opin Emerg Drugs. 2005 Feb;10(1):53-65.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.